Immunology and Microbiology
Adaptive Immune System
19%
Agonist
23%
Cancer Associated Fibroblast
61%
Cancer Cell
46%
Cancer Immunotherapy
7%
Cell Clone
30%
Cell Function
7%
Clostridium
11%
Coculture
17%
Cytotoxic T-Cell
30%
Dynamics
30%
Extracellular Matrix
15%
Feces microflora
30%
Germfree Mouse
30%
Granulocyte Macrophage Colony-Stimulating Factor
7%
Immune System
15%
Immunity
21%
Immunocompetent Cell
23%
Immunology
30%
Immunomics
15%
Immunosuppression
15%
Immunosuppressive Drug
63%
Immunotherapy
69%
Intestine Flora
17%
Leukocyte
15%
Lymph Node
38%
Lymphocyte
30%
Mass Cytometry
19%
Maturation
30%
Mesothelin
8%
Microbiome
35%
Microflora
30%
Molecular Interaction
30%
Mouse
64%
Multi-Omics
7%
Myeloid
61%
Myeloid-Derived Suppressor Cell
30%
Organoid
13%
Patient Coding
7%
RNA Sequence
31%
Sensitization
15%
STAT3
15%
T Cell
59%
T Cell Activation
12%
Tertiary Lymphoid Structure
30%
Transcriptome
7%
Transcriptomics
23%
Transfer of Learning
38%
Tumor Cell
19%
Tumor-Associated Macrophage
30%
Medicine and Dentistry
Breast Cancer
7%
Breast Tumor
30%
Cancer Associated Fibroblast
30%
Cancer Types
7%
Carcinogenesis
30%
CD137
30%
Cell Activation
10%
Cell Interaction
19%
Cell Proliferation
7%
Clinical Trial
61%
Cytotoxic T-Cell
30%
Dendritic Cell
8%
Entinostat
61%
Extracellular Matrix
15%
Gene Expression
7%
Hepatocellular Carcinoma
30%
Histone Deacetylase Inhibitor
8%
Immune Checkpoint Inhibitor
12%
Immunity
27%
Immunosuppressive Drug
41%
Immunosuppressive Treatment
35%
Immunotherapy
76%
Leukocyte
7%
Macrophage
11%
Memory T Cell
8%
Mesothelin
12%
Metastatic Carcinoma
7%
Myeloid Cell
47%
Myeloid-Derived Suppressor Cell
7%
Neoplasm
65%
Nivolumab
30%
Overall Survival
8%
Pancreas Adenocarcinoma
100%
Pancreas Adenoma
23%
Pancreas Cancer
30%
Phosphodiesterase V
30%
Precursor
7%
Progression Free Survival
8%
Proteomics
7%
RNA Sequence
17%
Small Cytoplasmic RNA
7%
Solid Malignant Neoplasm
8%
T Cell
36%
T Cell Activation
13%
Tadalafil
30%
Tertiary Lymphoid Structure
30%
Transcriptomics
53%
Transfer of Learning
7%
Tumor Immune Microenvironment
12%
Tumor Microenvironment
69%
Keyphrases
Accession number
30%
Adaptive Immunity
15%
Anti-tumor Response
36%
Antitumor Efficacy
12%
Apologizing
15%
Breast Tumor Microenvironment
30%
Cancer Cells
15%
Cancer Progression
15%
Cell Systems
30%
Chemotherapy Resistance
15%
Complex Networks
15%
Computational Methods
15%
Disease Progression
15%
Entinostat
61%
HER2+
30%
Immune Cells
15%
Immune Suppression
30%
Immune System
15%
Immunomics
15%
Immunosuppressive Myeloid Cells
12%
Last Digits
15%
Latent Space
30%
Leukocyte Trafficking
15%
Local Interaction
15%
Lymph Node
38%
Lymphocyte Dynamics
15%
Lymphocytes
15%
Mesothelin
12%
Metastatic Pancreatic Ductal Adenocarcinoma
30%
Molecular Interactions
30%
Myeloid Cells
47%
Nivolumab
30%
Pancreatic Ductal Adenocarcinoma
48%
Phase II Clinical Trial
30%
Phosphodiesterase Type 5 Inhibitors
30%
Regret
15%
Reverse Antibiotic
30%
Spatial Data Integration
30%
Spatial Landscape
61%
Systemic Interaction
15%
Systems Immunology
30%
Systems-based Approach
15%
T Cell Activation
12%
Tadalafil
30%
Tertiary Lymphoid Structures
30%
Therapeutic Response
15%
Tumor
41%
Tumor Cells
15%
Tumor Immune Microenvironment
12%
Tumor Microenvironment
50%
